Literature DB >> 7548376

Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey.

T Sisto1, A Reunanen, J Laurikka, O Impivaara, M Heliövaara, P Knekt, A Aromaa.   

Abstract

OBJECTIVE: To study the prevalence and risk factors of clinically important varicose veins in the lower extremities.
DESIGN: Cross-sectional study with self-administered questionnaire.
SETTING: A national health examination survey, Finland.
SUBJECTS: 8000 people from 40 geographical areas representing the adult population aged 30 years and over.
RESULTS: The prevalence of varicose veins diagnosed by a physician was 25% in women and 7% in men. Twenty-nine per cent of the men and 53% of the women with diagnosed varicose veins had been treated surgically. Age, height, body mass index (weight/height2), standing at work, and the number of births were expected risk factors associated with varicosities. Unexpectedly, signs of osteoarthrosis were positively, and diabetes negatively, associated with varicose veins. Urban dwelling and high income correlated positively with varicose veins treated surgically in women.
CONCLUSIONS: Varicose veins in the lower extremities are common, and demand considerable health service resources. The aetiology of varicose veins is still incompletely understood and more research is needed to develop possible preventive measures.

Entities:  

Mesh:

Year:  1995        PMID: 7548376

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  20 in total

1.  Socioeconomic variations in hysterectomy: evidence from a linkage study of the Finnish hospital discharge register and population census.

Authors:  R Luoto; I Keskimäki; A Reunanen
Journal:  J Epidemiol Community Health       Date:  1997-02       Impact factor: 3.710

2.  Socioeconomic status, occupation, and risk of hospitalisation due to coxarthrosis in Denmark 1981-99.

Authors:  F Tüchsen; H Hannerz; M V Jensen; N Krause
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Katie G Beauregard; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

4.  Clinical and Genetic Determinants of Varicose Veins.

Authors:  Eri Fukaya; Alyssa M Flores; Daniel Lindholm; Stefan Gustafsson; Daniela Zanetti; Erik Ingelsson; Nicholas J Leeper
Journal:  Circulation       Date:  2018-12-18       Impact factor: 29.690

5.  Venous pathophysiology.

Authors:  Chieh-Min Fan
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

6.  Impact of elevated serum estradiol/free testosterone ratio on male varicose veins in a prospective study.

Authors:  Sedat Özcan; Dolunay Odabasi; Tolga Kurt; Ali Kemal Gür; Aysegul Kunt; Yavuz Balaharoglu; Alper Sami Kunt
Journal:  Wien Klin Wochenschr       Date:  2014-11-20       Impact factor: 1.704

7.  Pregnancy-associated adaptations in [Ca2+]i-dependent and Ca2+ sensitization mechanisms of venous contraction: implications in pregnancy-related venous disorders.

Authors:  Yin Xia; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

8.  Chronic venous disease in an ethnically diverse population: the San Diego Population Study.

Authors:  Michael H Criqui; Maritess Jamosmos; Arnost Fronek; Julie O Denenberg; Robert D Langer; John Bergan; Beatrice A Golomb
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

9.  Heritability of chronic venous disease.

Authors:  Andreas Fiebig; Petra Krusche; Andreas Wolf; Michael Krawczak; Birgitt Timm; Susanna Nikolaus; Norbert Frings; Stefan Schreiber
Journal:  Hum Genet       Date:  2010-03-31       Impact factor: 4.132

10.  Sex-related decrease in [Ca2+]i signaling and Ca2+-dependent contraction in inferior vena cava of female rat.

Authors:  Yin Xia; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-28       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.